Enter search text:Fortis Healthcare board okays extending MD & CEO Ashutosh Raghuvanshi's tenure by 2 yearsPTILast Updated: Jul 08, 2026, 03:29:00 PM ISTSynopsisFortis Healthcare's board has approved Ashutosh Raghuvanshi's reappointment as Managing Director. His new term will commence on March 19, 2027, for a period of two years. This reappointment follows the conclusion of his current tenure on March 18, 2027. The board cited his expertise and role in the company's growth for this decision.AgenciesFortis Healthcare Ltd on Wednesday said its board has approved the reappointment of Ashutosh Raghuvanshi (In pic) as Managing Director.New Delhi: Fortis Healthcare Ltd on Wednesday said its board has approved reappointment of Ashutosh Raghuvanshi as Managing Director for a further period of two years effective from March 19, 2027.The current term of Raghuvanshi as Managing Director (designated as Managing Director and Chief Executive Officer) is expiring on March 18, 2027, Fortis Healthcare Ltd said in a regulatory filing.Considering the expertise and his role in steering the growth of the company, the board of directors in their meeting held on Wednesday recommended his re-appointment for a further period of two years, effective from March 19, 2027, it added.Read More: Cultural sensitivity, communication key to strengthening India's medical tourism appeal: IIM expertsThe reappointment is subject to approval of the shareholders, the company said.Read More News on...moreless
Fortis Healthcare board okays extending MD & CEO Ashutosh Raghuvanshi's tenure by 2 years
Fortis Healthcare's board has approved Ashutosh Raghuvanshi's reappointment as Managing Director. His new term will commence on March 19, 2027, for a period of two years. This reappointment follows the conclusion of his current tenure on March 18, 2027. The board cited his expertise and role in the company's growth for this decision.







